Press Trust of India on MSN28m
Rubicon Research, Sai Life Sciences, 2 others get Sebi's nod to float IPOs
Four companies, including pharmaceutical formulation firm Rubicon Research and TPG Capital-backed Sai Life Sciences, have ...
TPG Third Quarter 2024 Earnings: EPS: US$0.039 (vs US$0.14 in 3Q 2023)
Revenue: US$855.4m (up 433% from 3Q 2023). Net income: US$3.99m (down 66% from 3Q 2023). Profit margin: 0.5% (down from 7.3% ...
VCCircle46m
PE-backed pharma companies Sai Life and Rubicon Research get nod for IPO
Two homegrown healthcare companies, backed by private equity firms General Atlantic and TPG, have received approval from ...